Evaluating The Role of Intravenous Ketorolac in Preventing Post-Operative Pain in Patients Undergoing hemorrhoidectomy

Evaluating The Role of Intravenous Ketorolac in Preventing Post-Operative Pain in Patients Undergoing hemorrhoidectomy: a clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240808062692N1

Enrollment

Registered

2025-01-02

Start date

2024-09-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoid. Third degree hemorrhoids

Interventions

Intervention 1: Intervention group: The case group received 30 mg ketorolac intravenously immediately before induction of anesthesia and received pethidine after the operation if needed. The intensity

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with planned hemorrhoidectomy who are referred to Namazi hospital, Shiraz, Iran

Exclusion criteria

Exclusion criteria: drug addiction positive history of anxiety disorder or mental problems or sensory problems thrombotic hemorrhoids whom underwent local or spinal anesthesia

Design outcomes

Primary

Measure	Time frame
Pain degree. Timepoint: one and four and 24 hours after operation. Method of measurement: Subjective score of pain from ? (no pain) to ?? (severe pain).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHooman Rezaei

Shiraz University of Medical Sciences

hoomanr2000@gmail.com+98 71 3230 5410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026